Patent Documents

Patent applications for bulk sequences from other dicots

The following patent documents demonstrate attempts to patent large groups of sequences from other dicots.  These applications use claim language such that a successful claim would almost certainly cover large numbers of sequences from other dicots, and perhaps also some from Arabidopsis.  It is therefore useful to investigate briefly the claim contents of such applications – particularly since many of these applications are more recent than those of Paradigm Genetics, and, unlike the applications of Paradigm, appear to be in the process of active patenting efforts by the respective companies.

The claims of the Agrigenesis patent below refer to sequences derived from Eucalyptus grandis and Pinus radiata:

Patent or Publication No. Title, Independent Claims and Summary Applicant
US 2005/50583 A1

  • Earliest priority – 11 Jan 2000
  • Filed – 09 Jun 2004
  • Granted – Pending
  • Expected expiry – N/A
Title – Compositions isolated from plant cells and their use in the modification of plant cell signaling

Claim 1
An isolated polynucleotide comprising

  • a sequence selected from the group consisting of: sequences provided in SEQ ID NO: 1-67, 131-481, 833-888, 946-952 and 960-974.
Claim 2
An isolated polynucleotide comprising

  • a sequence selected from the group consisting of:
    • (a) complements of the sequence recited in SEQ ID NO: 1-67, 131-481, 833-888, 946-952 and 960-974;
    • (b) reverse complements of the sequence recited in SEQ ID NO: 1-67, 131-481, 833-888, 946-952 and 960-974;
    • (c) reverse sequences of the sequences recited in SEQ ID NO: 1-67, 131-481, 833-888, 946-952 and 960-974;
    • (d) sequences that are 100-mers of a sequence of SEQ ID NO: 1-67, 131-481, 833-888, 946-952 and 960-974;
    • (e) sequences that are 40-mers of a sequence of SEQ ID NO: 1-67, 131-481, 833-888, 946-952 and 960-974; and
    • (f) sequences that are 20-mers of a sequence of SEQ ID NO: 1-67, 131-481, 833-888, 946-952 and 960-974.
Claim 3
An isolated polynucleotide comprising

  • a sequence selected from the group consisting of:
    • (a) sequences having at least 75% identity to a sequence of SEQ ID NO: 1-67, 131-481, 833-888, 946-952 and 960-974;
    • (b) sequences having at least 90% identity to a sequence of SEQ ID NO: 1-67, 131-481, 833-888, 946-952 and 960-974;
    • (c) sequences having at least 95% identity to a sequence of SEQ ID NO: 1-67, 131-481, 833-888, 946-952 and 960-974;
    • (d) sequences having at least 98% identity to a sequence of SEQ ID NO: 1-67, 131-481, 833-888, 946-952 and 960-974; and
    • (e) sequences that hybridize to a sequence of SEQ ID NO: 1-67, 131-481, 833-888, 946-952 and 960-974 under stringent hybridization conditions, wherein the polynucleotide encodes a polypeptide having substantially the same functional activity as a polypeptide encoded by a polynucleotide of SEQ ID NO: 1-67, 131-481, 833-888, 946-952 and 960-974.
Claim 5
An isolated polypeptide comprising

  • an amino acid sequence selected from the group consisting of: SEQ ID NO: 68-130, 482-832, 889-945, 953-959 and 975-989.
Claim 6
An isolated polypeptide comprising

  • an amino acid sequence selected from the group consisting of:
    • (a) sequences having at least 75% identity to a sequence of SEQ ID NO: 68-130, 482-832, 889-945, 953-959 and 975-989;
    • (b) sequences having at least 90% identity to a sequence of SEQ ID NO: 68-130, 482-832, 889-945, 953-959 and 975-989; and
    • (c) sequences having at least 95% identity to a sequence of SEQ ID NO: 68-130, 482-832, 889-945, 953-959 and 975-989, wherein the polypeptide has substantially the same functional properties as a polypeptide of SEQ ID NO: 68-130, 482-832, 889-945, 953-959 and 975-989.

The claims are generally drawn to:

  • Polynucleotides cited. (Claim 1)
  • Polynucleotides consisting of: (Claim 2)
    • (a) complements of the sequence recited
    • (b) reverse complements of the sequence recited
    • (c) reverse sequences of the sequences recited
    • (d) sequences that are 100-mers cited sequences
    • (e) sequences that are 40-mers of cited sequences
    • (f) sequences that are 20-mers of cited sequences
  • Polynucleotide consisting of: (Claim 3)
    • (a) sequences having at least 75% identity to cited sequences
    • (b) sequences having at least 90% identity to cited sequences
    • (c) sequences having at least 95% identity to cited sequences
    • (d) sequences having at least 98% identity to cited sequences
    • (e) sequences that hybridize to cited sequences under stringent conditions, and the encoded polypeptide has a similar functional activity to the polypeptide encoded by the cited sequences.
  • Polypeptides consisting of the cited sequences.(Claim 5)
  • Polypeptides consisting of: (Claim 6)
    • (a) sequences having at least 75% identity to a cited sequences
    • (b) sequences having at least 90% identity to cited sequences and
    • (c) sequences having at least 95% identity to cited sequences, where the polypeptide has similar function to the cited polypeptide sequences.

The sequences above were derived from:

  1. Eucalyptus grandis (SEQ ID NO: 2, 8, 9, 11, 15, 18, 19, 21-25, 33, 34, 38, 42, 48-52, 55-58, 67, 131-301, 448-471, 474-478, 848, 850-874, 882-887, 946-952, 960-967 and 971-974)
  2. Pinus radiata (SEQ ID NO: 1, 3-7, 10, 12-14, 16, 17, 20, 26-32, 35-37, 39-41, 43-47, 53, 54, 59-66, 302-447, 472, 473, 479-481, 833-847, 849, 875-881, 888, and 968-970)

Original Applicant:
AGRIGENESIS BIOSCIENCES LIMITED,
Parnell, Auckland, NZ.